Dolby Laboratories, Inc.
DLB
$75.75
-$0.04-0.05%
NYSE
| 12/27/2024 | 09/27/2024 | 06/28/2024 | 03/29/2024 | 12/29/2023 | |
|---|---|---|---|---|---|
| Revenue | 1.32B | 1.27B | 1.26B | 1.27B | 1.28B |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 1.32B | 1.27B | 1.26B | 1.27B | 1.28B |
| Cost of Revenue | 149.21M | 140.50M | 142.05M | 147.90M | 150.18M |
| Gross Profit | 1.17B | 1.13B | 1.12B | 1.12B | 1.13B |
| SG&A Expenses | 625.17M | 604.85M | 605.22M | 613.98M | 614.83M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 1.04B | 1.01B | 1.01B | 1.03B | 1.04B |
| Operating Income | 277.49M | 264.71M | 246.75M | 238.50M | 241.28M |
| Income Before Tax | 317.70M | 312.48M | 261.78M | 235.37M | 230.90M |
| Income Tax Expenses | 52.89M | 48.16M | 46.42M | 43.26M | 41.13M |
| Earnings from Continuing Operations | 264.81 | 264.32 | 215.36 | 192.11 | 189.78 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -2.14M | -2.49M | -2.92M | -1.71M | -1.52M |
| Net Income | 262.67M | 261.83M | 212.44M | 190.40M | 188.26M |
| EBIT | 277.49M | 264.71M | 246.75M | 238.50M | 241.28M |
| EBITDA | 357.54M | 340.27M | 322.08M | 316.56M | 322.56M |
| EPS Basic | 2.75 | 2.74 | 2.22 | 1.99 | 1.97 |
| Normalized Basic EPS | 2.09 | 2.06 | 1.93 | 1.85 | 1.84 |
| EPS Diluted | 2.71 | 2.70 | 2.19 | 1.96 | 1.93 |
| Normalized Diluted EPS | 2.06 | 2.03 | 1.90 | 1.82 | 1.81 |
| Average Basic Shares Outstanding | 382.41M | 382.18M | 382.48M | 382.45M | 382.56M |
| Average Diluted Shares Outstanding | 387.56M | 387.85M | 388.93M | 389.43M | 389.87M |
| Dividend Per Share | 1.26 | 1.23 | 1.20 | 1.17 | 1.14 |
| Payout Ratio | 44.76% | 43.76% | 52.62% | 57.21% | 56.35% |